EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Role of iron and iron chelation therapy in oxygen free radical mediated tissue injury in an ascending mouse model of chronic pyelonephritis



Role of iron and iron chelation therapy in oxygen free radical mediated tissue injury in an ascending mouse model of chronic pyelonephritis



Comparative Immunology, Microbiology and Infectious Diseases 20(4): 299-307



The contribution of iron towards the free radical generation leading to renal tissue damage was assessed using a non-obstructive ascending mouse model for chronic pyelonephritis. The parameters studied include luminol dependent chemiluminescence (LDCL), histopathology and some biochemical investigations. We found that iron enhanced the renal tissue damage and led to renal scarring, and end point in chronic renal inflammation, irrespective of the bacterial strain studied. In addition a role of iron chelation therapy as a treatment for chronic renal inflammation is also suggested.

(PDF emailed within 1 workday: $29.90)

Accession: 047286045

Download citation: RISBibTeXText

PMID: 9481514



Related references

Role of iron and iron chelation therapy in oxygen free radical mediated tissue injury in an ascending mouse model of chronic pyelonephritis. Comparative Immunology Microbiology & Infectious Diseases 20(4): 299-307, Sept, 1997

Prevention of tissue injury in an ascending mouse model of chronic pyelonephritis - role of free radical scavengers. Comparative Immunology Microbiology & Infectious Diseases 27(4): 225-234, July, 2004

Postischemic tissue injury by iron-mediated free radical lipid peroxidation. Annals of Emergency Medicine 14(8): 804-809, 1985

Transferrin: a potential source of iron for oxygen free radical-mediated endothelial cell injury. Archives of Biochemistry and Biophysics 294(1): 265-270, 1992

Oxygen free radical damage nucleotide iron ii mediated hydroxyl free radical formation and high pressure oxygen induced lipid per oxidation in brain. Federation Proceedings 42(7): ABSTRACT 1464, 1983

Iron-mediated free radical injury in ethanol-exposed mouse neural crest cells. Journal of Pharmacology and Experimental Therapeutics 294(1): 134-140, 2000

Reactive oxygen species-mediated tissue injury in experimental ascending pyelonephritis. Kidney International 49(1): 26-33, 1996

A new era in iron chelation therapy: the design of optimal, individually adjusted iron chelation therapies for the complete removal of iron overload in thalassemia and other chronically transfused patients. Hemoglobin 33(5): 332-338, 2010

Iron-Overload Cardiomyopathy: Evidence for a Free Radical- Mediated Mechanism of Injury and Dysfunction in a Murine Model. Biological Research for Nursing 2(1): 49-59, 2000

Iron-overload cardiomyopathy: evidence for a free radical--mediated mechanism of injury and dysfunction in a murine model. Biological Research for Nursing 2(1): 49-59, 2001

Iron overload and iron chelation therapy in patients with myelodysplastic syndrome treated by allogeneic stem-cell transplantation: report from the working conference on iron chelation of the Gruppo Italiano Trapianto di Midollo Osseo. American Journal of Hematology 86(10): 897-902, 2011

A promising approach for improving the recovery of heart transplants. Prevention of free radical injury through iron chelation by deferoxamine. Journal of Thoracic and Cardiovascular Surgery 100(1): 13-21, 1990

Use of iron chelators in preventing hydroxyl radical damage: adult respiratory distress syndrome as an experimental model for the pathophysiology and treatment of oxygen-radical-mediated tissue damage. Acta Haematologica 95(1): 49-62, 1996

Milk whey protein decreases oxygen free radical production in a murine model of chronic iron-overload cardiomyopathy. Canadian Journal of Cardiology 19(10): 1163-1168, 2003

Role of zinc and iron chelation in apoptosis mediated by tachpyridine, an anti-cancer iron chelator. Biochemical Pharmacology 67(9): 1677-1688, 2004